JONATHAN BECKER: Open Payments
NPI 1487897146 · BRENTWOOD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,670 in 76 payments from 12 companies in 2025. Trend: 2023 $1,332 · 2024 $1,608 · 2025 $1,670
Food & beverage: $1,670
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $486 |
| Axsome Therapeutics, Inc. | 12 | $296 |
| Alkermes, Inc. | 8 | $197 |
| ABBVIE INC. | 14 | $194 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| Janssen Pharmaceuticals, Inc | 5 | $105 |
| E.R. Squibb & Sons, L.L.C. | 4 | $102 |
| Noven Therapeutics, LLC | 4 | $65 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $32 |
Products named: CAPLYTA, Auvelity, VRAYLAR, ARISTADA, REXULTI, SPRAVATO, COBENFY, Xelstrym.
Industry payments across TN — which companies pay providers there.
